Lars Skjærven

Title: Lars Skjærven: Innovator in Pharmacological Treatments

Introduction

Lars Skjærven is a notable inventor based in Bergen, Norway. He has made significant contributions to the field of pharmacology, particularly in the treatment of metabolic disorders. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Lars Skjærven holds a patent for his invention titled "Hyperphenylalaninemia and treatments thereof." This patent relates to compounds of formula (I) that serve as pharmacological chaperones. These compounds have a stabilizing effect on phenylalanine hydroxylase (PAH) for the treatment of hyperphenylalaninemia (HPA), especially phenylketonuria (PKU). The compounds include trimethoprim and its analogues and derivatives.

Career Highlights

Throughout his career, Lars has worked with various organizations that focus on technological advancements and innovation. He has been associated with Bergen Teknologioverføring AS and Vestlandets Innovasjonsselskap AS, where he contributed to the development of new technologies and solutions.

Collaborations

Lars has collaborated with several professionals in his field, including Jarl Underhaug and Ming Ying. These partnerships have enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Lars Skjærven is a distinguished inventor whose work in pharmacological treatments has the potential to improve the lives of individuals affected by metabolic disorders. His innovative approach and collaborations highlight the importance of research in developing effective therapies.